The oncology reimbursement landscape continues to present ever-evolving challenges for femara and zometa breast cancer regimen and others that work with patients with cancer.
Select a cancer or supportive care indication or select a reimbursement program below to learn about reimbursement help and services available to you to help your practice mitigate reimbursement challenges, femara and zometa breast cancer regimen. Now available for Apple and Android smartphones and tablets! As a response to these ongoing challenges, help is available through the NCCN Reimbursement Resource App; users are able to search for available resources and payment assistance programs, femara and zometa breast cancer regimen.
Information on resources available are listed under three different tabs entitled: A printer-friendly 23 page resource to empower patients with cancer and their caregivers as you help them navigate the challenging reimbursement landscape. Neratinib is a once-daily oral medicine for women who have just finished trastuzumab therapy i. Reimbursement and Patient Assistance Programs. Ado-trastuzumab emtansine Kadcyla Genentech Access Solutions.
Erlotinib Tarceva Genentech Access Solutions. Pertuzumab Perjeta Genentech Access Solutions. Rituximab Rituxan Genentech Access Solutions. Vemurafenib Zelboraf Genentech Access Solutions. We are here to answer questions about your insurance coverage and options for filling your prescription in order to get you started on therapy as quickly as possible.
This program provides free XTANDI to patients who qualify for enrollment based on insurance and household income femara and zometa breast cancer regimen. Eligibility is determined on a patient-specific basis. Box La Jolla, CA For Full Prescribing Information please see www. AstraZeneca Access is a trademark of the AstraZeneca group of companies.
AstraZeneca does not guarentee reimbursement. Femara and zometa breast cancer regimen Squibb is committed to helping appropriate patients initiate and maintain access to our medications during the treatment journey.
The Oncology Co-pay Assistance Program assists with out-of-pocket co-payment or co-insurance requirements for eligible, commercially insured patients who have been prescribed certain Bristol-Myers Squibb oncology products. If you are concerned about paying for your Genentech medicine, we are here to help.
Whether you have health care coverage or not, we house plans and 6 bedrooms help you by:. IncyteCARES assists healthcare professionals and eligible patients with product access through a suite of services, including:. Janssen CarePath is your one source for resources focused on access, affordability, and treatment support for your patients.
Our dedicated Care Coordinator team supports all the Janssen medications you prescribe. We can help make it easier for your patients and you to get the resources you both may need. Janssen CarePath helps verify insurance coverage for your patients and provides reimbursement information. Affordability support to help your patients start and stay on treatment you prescribe. Treatment support to help your patients get informed and stay on prescribed treatment Janssen CarePath helps keep your patients informed about their condition and the importance of staying on treatment with:.
Janssen CarePath understands that navigating payer femara and zometa breast cancer regimen and finding cost support options may seem complicated at times. Janssen CarePath Care Coordinator We have no control over these independent foundations and can only refer your patients to a foundation that supports their disease state, femara and zometa breast cancer regimen.
We do not endorse any particular foundation. Jazz Pharmaceuticals is committed to improving patient care through unique patient and physician programs and ongoing collaboration with patients, physicians, and advocacy groups, femara and zometa breast cancer regimen. Dedicated Reimbursement Specialists are available to assist patients with reimbursement for VYXEOS who have started treatment in either the inpatient or outpatient setting. Reimbursement specialists can assist with the inpatient and outpatient setting with a number of things, including:.
The Lilly PatientOne program is committed to helping eligible patients access support programs for Lilly Oncology products they are prescribed. It aims to address both financial and coverage issues for qualified uninsured, underinsured, and insured patients who are prescribed a Lilly Oncology product. PatientOne strives to offer resources, ranging from nexium and cost investigations to financial assistance and appeals information, that provide reliable and individualized treatment support for eligible patients.
Reimbursement assistance for eligible Lilly Oncology products for an approved diagnosis. Novartis Oncology is committed to helping patients living with cancer receive the medicines they need. Patient Assistance Now Oncology PANO offers quick and easy access to information about the broad array of support and reimbursement programs available. The Patient Access Network PAN Foundation is an independent, national c 3 organization dedicated to helping federally and commercially insured people living with life-threatening, chronic and rare diseases with the out-of-pocket costs for their prescribed medications.
Partnering with generous donors, healthcare providers and pharmacies, PAN provides the underinsured population access to the healthcare treatments they need to best manage their conditions and focus on improving their quality of life. For more information please visit http: Access and reimbursement support i. Some of the options include benefit verification, prior authorization support and customer service through the claims and appeals process. For more information or an introductory consult please call or visit www.
Affordability Support Regardless of insurance type, we can help your patients understand their options. Provide needed information on reimbursement programs and service available. National Comprehensive Cancer Network. Know What Your Doctors Know: Impact on Practice, Nov. Prostate Cancer Patient Management Simulator.
Panel Video 1 Patient Advocacy Summit: Panel Video 2 Patient Advocacy Summit: Panel Video 3 Patient Advocacy Summit: Value in Cancer Care - Patient Perspectives: Submit by October 24, Informed Consent Language Database. Factsheets on Key Cancer Topics. The NCCN Virtual Reimbursement Resource Guide A printer-friendly 23 page resource to empower patients with cancer and their caregivers as you help them navigate the challenging reimbursement landscape. Astellas Pharma US, Inc, femara and zometa breast cancer regimen.
Flexible and integrated resources for patient access and support: Patient Access, Reimbursement, and Co-Pay Support Available Through Bristol-Myers Squibb is committed to helping appropriate patients initiate and maintain access to our medications during the treatment journey. Enroll online at celgenepatientsupport. Whether you have health care coverage or not, we can help you by: Finding out if your health care plan pays for your medicine Guiding you through the process of getting your medicine Connecting you with our patient assistance programs Visit Genentech-Access.
IncyteCARES assists healthcare professionals and eligible patients with product access through a suite of services, including: Janssen CarePath Janssen CarePath is your one source for resources focused on access, affordability, and treatment support for your patients.
Access support to help navigate payer process. Benefits investigation support Prior authorization support and status monitoring Information on the exceptions and appeals process Coding and billing information, if needed Triage to specialty pharmacy providers, if needed Patient Account and Provider Portal for convenient online benefits investigation, prior authorization support, and other resources Affordability support to help your patients start and stay on treatment you prescribe Janssen CarePath can help you femara and zometa breast cancer regimen out what affordability assistance may be available for your patients taking Janssen medicines: Support for patients using commercial or private insurance: Janssen CarePath Savings Program allows eligible patients to save on out-of-pocket medication costs for their Janssen brand.
Terms expire at the end of each calendar year and may change. There is no income plan b and pregnancy. Request benefits investigations Review the status of benefits investigations Enroll your eligible, commercially insured patients in the Janssen CarePath Savings Program View savings program femara and zometa breast cancer regimen for enrolled patients Receive notifications when new information is available or action is required on the Portal Janssen CarePath Patient Account Patients can create a Janssen CarePath Account at MyJanssenCarePath.
Jazz Pharmaceuticals Jazz Pharmaceuticals is committed to improving patient care through unique patient and physician programs and ongoing collaboration with patients, physicians, and advocacy groups.
Reimbursement specialists can assist with the inpatient and outpatient setting with a number of things, including: Services offered by this program include: Insurance expertise Coding and billing information Payment methodologies and allowables Payer policy information Patient Assistance Program Drug replacement for eligible patients Financial assistance Information about co-pay assistance foundations Co-pay program to assist eligible patients with out-of-pocket costs for specific Lilly Oncology products where available Reimbursement assistance for eligible Lilly Oncology products for an approved diagnosis Eligibility determination Benefits investigation Prior authorization Evaluation of other funding options Denied claim appeals Appeals status if requested Denied claims appeals templates, forms, and checklists For more information call PatOne Monday—Friday, 9AM—7PM ET or visit www.
The Merck Access Program may help answer questions about: You can get information about our PANO support programs in 2 ways: Call to speak with a member of our knowledgeable staff dedicated to making access to our programs as simple and convenient as possible; or HCPs visit our website at: Free drug is provided to uninsured patients who meet certain financial qualifications.
Not valid for federal and state healthcare program beneficiaries. Not femara and zometa breast cancer regimen for patients enrolled in Medicare or Medicaid Independent Foundations: If your patients need additional financial support, we can provide them with information on independent foundations Other Resources: JJPAF is committed to providing access to medicines for uninsured individuals who lack the financial resources to pay for them.